Meanwhile, traditional herbal medicines, due to their multi-component synergistic mechanisms of action (such as salidroside regulating the HPA axis and psilocybin/psilocin regulating 5-HT2A), are increasingly gaining attention in the field of depression treatment, offering new directions for developing low-side-effect, multi-pathway intervention strategies. This evidence concerns the gene HTR2A and depressive disorder.